An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases.

Saved in:
Bibliographic Details
Title: An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases.
Authors: Liu P; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Pan Z; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Gu C; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Cao X; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Liu X; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Zhang J; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Xiao Z; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Wang X; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Guo H; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Ju D; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China., Deng SJ; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.
Source: Frontiers in immunology [Front Immunol] 2020 Nov 27; Vol. 11, pp. 596908. Date of Electronic Publication: 2020 Nov 27 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33329588
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+P%22">Liu P</searchLink>; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Pan+Z%22">Pan Z</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Gu+C%22">Gu C</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Cao+X%22">Cao X</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Xiao+Z%22">Xiao Z</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Guo+H%22">Guo H</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Ju+D%22">Ju D</searchLink>; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Deng+SJ%22">Deng SJ</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2020 Nov 27; Vol. 11, pp. 596908. <i>Date of Electronic Publication: </i>2020 Nov 27 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33329588
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2020.596908
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 596908
    Titles:
      – TitleFull: An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu P
      – PersonEntity:
          Name:
            NameFull: Pan Z
      – PersonEntity:
          Name:
            NameFull: Gu C
      – PersonEntity:
          Name:
            NameFull: Cao X
      – PersonEntity:
          Name:
            NameFull: Liu X
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Xiao Z
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Guo H
      – PersonEntity:
          Name:
            NameFull: Ju D
      – PersonEntity:
          Name:
            NameFull: Deng SJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 11
              Text: 2020 Nov 27
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1